144 related articles for article (PubMed ID: 17495961)
1. Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.
Gesser B; Johansen C; Rasmussen MK; Funding AT; Otkjaer K; Kjellerup RB; Kragballe K; Iversen L
J Invest Dermatol; 2007 Sep; 127(9):2129-37. PubMed ID: 17495961
[TBL] [Abstract][Full Text] [Related]
2. Dimethylfumarate inhibits NF-{kappa}B function at multiple levels to limit airway smooth muscle cell cytokine secretion.
Seidel P; Merfort I; Hughes JM; Oliver BG; Tamm M; Roth M
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L326-39. PubMed ID: 19465513
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling.
Peng H; Guerau-de-Arellano M; Mehta VB; Yang Y; Huss DJ; Papenfuss TL; Lovett-Racke AE; Racke MK
J Biol Chem; 2012 Aug; 287(33):28017-26. PubMed ID: 22733812
[TBL] [Abstract][Full Text] [Related]
4. Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.
Gesser B; Rasmussen MK; Raaby L; Rosada C; Johansen C; Kjellerup RB; Kragballe K; Iversen L
Inflamm Res; 2011 Jul; 60(7):643-53. PubMed ID: 21340650
[TBL] [Abstract][Full Text] [Related]
5. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
Funding AT; Johansen C; Kragballe K; Otkjaer K; Jensen UB; Madsen MW; Fjording MS; Finnemann J; Skak-Nielsen T; Paludan SR; Iversen L
J Invest Dermatol; 2006 Aug; 126(8):1784-91. PubMed ID: 16543895
[TBL] [Abstract][Full Text] [Related]
6. Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
Gerdes S; Shakery K; Mrowietz U
Br J Dermatol; 2007 May; 156(5):838-42. PubMed ID: 17381463
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKKα/β Kinases and Regulates NF-κB /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatment with Dimethyl Fumarate.
Gesser B; Rasmussen MK; Iversen L
Psoriasis (Auckl); 2020; 10():1-11. PubMed ID: 32309199
[TBL] [Abstract][Full Text] [Related]
8. IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES.
Seidel P; Roth M; Ge Q; Merfort I; S'ng CT; Ammit AJ
Eur Respir J; 2011 Dec; 38(6):1444-52. PubMed ID: 21719482
[TBL] [Abstract][Full Text] [Related]
9. IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms.
Otkjaer K; Kragballe K; Johansen C; Funding AT; Just H; Jensen UB; Sørensen LG; Nørby PL; Clausen JT; Iversen L
J Invest Dermatol; 2007 Jun; 127(6):1326-36. PubMed ID: 17255956
[TBL] [Abstract][Full Text] [Related]
10. Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis.
Funding AT; Johansen C; Kragballe K; Iversen L
J Invest Dermatol; 2007 Aug; 127(8):2012-9. PubMed ID: 17429437
[TBL] [Abstract][Full Text] [Related]
11. Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells.
Loewe R; Holnthoner W; Gröger M; Pillinger M; Gruber F; Mechtcheriakova D; Hofer E; Wolff K; Petzelbauer P
J Immunol; 2002 May; 168(9):4781-7. PubMed ID: 11971029
[TBL] [Abstract][Full Text] [Related]
12. Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Haarmann A; Nehen M; Deiß A; Buttmann M
Int J Mol Sci; 2015 Aug; 16(8):19086-95. PubMed ID: 26287168
[TBL] [Abstract][Full Text] [Related]
13. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.
Ockenfels HM; Schultewolter T; Ockenfels G; Funk R; Goos M
Br J Dermatol; 1998 Sep; 139(3):390-5. PubMed ID: 9767281
[TBL] [Abstract][Full Text] [Related]
14. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts.
Kefaloyianni E; Gaitanaki C; Beis I
Cell Signal; 2006 Dec; 18(12):2238-51. PubMed ID: 16806820
[TBL] [Abstract][Full Text] [Related]
15. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-induced IL-8/CXCL8 release is mediated by CK2, MSK1, and NF-κB pathways in human lung epithelial cells.
Lin CH; Shih CH; Chen BC
Eur J Pharmacol; 2015 Nov; 767():135-43. PubMed ID: 26463037
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of IL-6 production by astaxanthin via ERK-, MSK-, and NF-κB-mediated signals in activated microglia.
Kim YH; Koh HK; Kim DS
Int Immunopharmacol; 2010 Dec; 10(12):1560-72. PubMed ID: 20932499
[TBL] [Abstract][Full Text] [Related]
18. Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
Loewe R; Pillinger M; de Martin R; Mrowietz U; Gröger M; Holnthoner W; Wolff K; Wiegrebe W; Jirovsky D; Petzelbauer P
J Invest Dermatol; 2001 Dec; 117(6):1363-8. PubMed ID: 11886496
[TBL] [Abstract][Full Text] [Related]
19. CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways.
Riis JL; Johansen C; Vestergaard C; Otkjaer K; Kragballe K; Iversen L
Cytokine; 2011 Dec; 56(3):699-707. PubMed ID: 21993219
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement.
Soegaard-Madsen L; Johansen C; Iversen L; Kragballe K
Br J Dermatol; 2010 Jun; 162(6):1216-23. PubMed ID: 20346019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
